Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies.

Haraoui, Boulos; Casado, Gustavo; Czirják, László; Taylor, Andrew; Dong, Lingli; Button, Peter; Luder, Yves; Caporali, Roberto

Haraoui, Boulos; Casado, Gustavo; Czirják, László; Taylor, Andrew; Dong, Lingli; Button, Peter; Luder, Yves; Caporali, Roberto.

Afiliação

Haraoui B; Institut de Rhumatologie de Montréal, Montreal, Canada. paulharaoui@videotron.ca.
Casado G; Department of Rheumatology, Hospital Militar Central, Buenos Aires, Argentina.
Czirják L; Rheumatology and Immunology Clinic, Medical Center, University of Pécs, Pécs, Hungary.
Taylor A; Medicine and Pharmacology RPH Unit, Royal Perth Hospital, University of Western Australia, Perth, Australia.
Dong L; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Button P; OzBiostat Pty Ltd, Manly, Australia.
Luder Y; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
Caporali R; Department of Rheumatology, University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy.

Rheumatol Ther ; 6(2): 231-243, 2019 Jun.

Article em En | MEDLINE | ID: mdl-30859494

Palavras-chave

ACT-UP; Biologic factors; Rheumatoid arthritis; Tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google